Analystreport

Health Catalyst, Inc. (NASDAQ: HCAT) had its price target raised by analysts at Wells Fargo & Company from $11.00 to $13.00.

Health Catalyst, Inc - Common stock  (HCAT) 
Last health catalyst, inc - common stock earnings: 2/27 04:05 pm Check Earnings Report